By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and New England Biolabs announced on Tuesday a non-exclusive licensing agreement for the commercialization of the Gibson Assembly Master Mix.

The deal calls for NEB to commercialize the product, which is based on the Gibson Assembly method, developed by Daniel Gibson and colleagues at the J. Craig Venter Institute as part of a program sponsored by Synthetic Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.